Article Text
PDF
Statistics from Altmetric.com
COVID-19 and return to play
The world of sport has recently returned to training and competition following suspension due to the COVID-19 pandemic. It is concerning that a number of athletes have tested positive for COVID-19 after returning to competition.1 Numerous authors have attempted to address return to play given the importance and complexity of the issue, with notable attention on possible cardiac implications.2–6
Scope of the infographic
The specific recommendations shown in the present infographic (figure 1) have been generated by a panel of international experts and represent a compilation of the numerous approaches used to inform resumption of regular sports during the COVID-19 pandemic. Despite the different regulations around the world and the particular characteristics of each sport, it is essential to provide informative, consistent and specific guidance for safe return to training and competition at this most difficult time.
Recommendations for return to sport during the COVID-19 pandemic. BNP, brain natriuretic peptide; CRP, C-reactive protein.
Recommendations
COVID-19 is a systemic disease affecting the endothelium and all organs, especially the heart and lungs with more severity and clinical significance. Therefore, our recommendations for safe return to sport are based on a comprehensive clinical evaluation (ie, cardiac and respiratory) and have been designed for six different groups according to the level of exposure to COVID-19. These groups are based on a previous report by Phelan et al,3 which are applicable to both leisure time and professional athletes. It is imperative that group allocation is determined beforehand through a medical examination performed in cooperation with a respiratory physician and/or cardiologist. Specific recommendations for each group are provided based on current evidence and expert opinion (see table 1).
Clinical recommendations for testing individual groups
Special considerations
The resumption of sporting activity should be determined on a case-by-case basis and consider the individual situation of the athlete, including pre-existing conditions, as well as the type of sport and the risk of infection from other athletes (eg, increased risk in contact/team sports). Ideally, the final decision to return to play will be based on the results of the individual assessment in consultation with the sport and exercise medicine physician, specialists in pulmonary medicine and sport cardiologists (or extended multidisciplinary team), coaches and training specialists. After a prolonged period of interruption in sport caused by more severe health issues, increments in training should be gradual, individualised and supervised by periodic monitoring of cardiac and respiratory markers to detect potential signs and symptoms. Although the present recommendations are focused primarily on pulmonary and cardiac assessments, given the wider health-related issues caused by COVID-19, more comprehensive evaluation including psychological status, examination of muscular function and other suspected collateral issues should be considered to provide more detailed and thorough information for safe return to play.
Footnotes
Twitter @Dora_Sportmed, @JBilzon, @rinsho, @PSingleton33
Correction notice This article has been corrected since it published Online First. Ref 8 has been corrected.
Contributors All authors contributed significantly and in line with the instructions to authors to merit publication.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; externally peer reviewed.